Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-01-28 | New | $5,000,000 | Unknown | Debt Only | SEC link | |
| 2026-01-28 | New | $5,000,000 | Unknown | Debt Only | SEC link | |
| 2024-07-15 | New | $15,000,000 | $15,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| David Cory | Director, Executive |
| Thomas Folinsbee | Director |
| Wei Gao | Executive |
| Wei Wu He | Director |
| Hai Huang | Executive |
| James Huang | Director |
| Barbara Krebs Pohl | Director |
| Kun Qian | Executive |
| Zhenbo Su | Director |
| Chunhua Wang | Executive |
| Alexander Y. Wu | Director |
| Xuebo Zeng | Director |
| Wei (Larry) Zhang | Executive |
| Alexander A. Zukiwski | Executive |